Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 15, 2024
Abstract
The
treatment
of
brain
diseases
has
always
been
the
focus
attention.
Due
to
presence
blood‐brain
barrier
(BBB),
most
small
molecule
drugs
are
difficult
reach
brain,
leading
undesirable
therapeutic
outcomes.
Recently,
nanomedicines
that
can
cross
BBB
and
precisely
target
lesion
sites
have
emerged
as
thrilling
tools
enhance
early
diagnosis
treat
various
intractable
disorders.
Extensive
research
shown
reactive
oxygen
species
(ROS)
play
a
crucial
role
in
occurrence
progression
diseases,
including
tumors
neurodegenerative
(NDDs)
such
Alzheimer's
disease,
Parkinson's
stroke,
or
traumatic
injury,
making
ROS
potential
target.
In
this
review,
on
structure
function
well
mechanisms
first
elaborated
through
which
nanomedicine
traverses
it.
Then,
recent
studies
production
summarized
photodynamic
therapy
(PDT),
chemodynamic
(CDT),
sonodynamic
(SDT)
for
treating
tumors,
depletion
NDDs.
This
provides
valuable
guidance
future
design
ROS‐targeted
disease
treatment.
ongoing
challenges
perspectives
developing
nanomedicine‐based
management
also
discussed
outlined.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(36)
Published: Oct. 28, 2023
Abstract
With
the
changing
disease
spectrum,
atherosclerosis
has
become
increasingly
prevalent
worldwide
and
associated
diseases
have
emerged
as
leading
cause
of
death.
Due
to
their
fascinating
physical,
chemical,
biological
characteristics,
nanomaterials
are
regarded
a
promising
tool
tackle
enormous
challenges
in
medicine.
The
emerging
discipline
nanomedicine
filled
huge
application
gap
atherosclerotic
field,
ushering
new
generation
diagnosis
treatment
strategies.
Herein,
based
on
essential
pathogenic
contributors
atherogenesis,
well
distinct
composition/structural
synthesis
strategies,
surface
design
nanoplatforms,
three
major
branches
(nanodiagnosis,
nanotherapy,
nanotheranostic)
elaborated.
Then,
state‐of‐art
studies
containing
sequence
representative
significant
achievements
summarized
detail
with
an
emphasis
intrinsic
interaction/relationship
between
nanomedicines
atherosclerosis.
Particularly,
attention
is
paid
biosafety
nanomedicines,
which
aims
pave
way
for
future
clinical
translation
this
burgeoning
field.
Finally,
comprehensive
review
concluded
by
proposing
unresolved
key
scientific
issues
sharing
vision
expectation
future,
fully
elucidating
closed
loop
from
atherogenesis
paradigm
advancing
early
achievement
applications.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(33)
Published: March 3, 2024
Abstract
The
immune
microenvironment
is
critical
for
the
occurrence,
progression,
and
treatment
of
diseases.
Ultrasound
tissue
engineering
technology
utilizes
ultrasound
principles
to
repair,
regenerate,
functionally
reconstruct
biological
tissues.
therapy
a
non‐invasive
modality
that
regulates
maintains
homeostasis
through
various
characteristic
effects.
Ultrasound‐responsive
biomaterials
utilize
properties
or
drug/gene
delivery
regulate
under
stimulation
targeted
purposeful
treatment.
This
article
comprehensively
systematically
reviews
advancements
in
regulating
microenvironment.
First,
changes
at
different
stages
disease
briefly
illustrated.
It
then
reviewed
regulation
by
ultrasound‐responsive
five
types
diseases:
tumor,
cardiovascular
system
diseases,
nervous
musculoskeletal
wound.
Finally,
prospects
summarized.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
206, P. 107289 - 107289
Published: July 1, 2024
Atherosclerosis
is
a
chronic
inflammatory
vascular
disease
characterized
by
lipid
metabolism
disorder
and
accumulation.
Equisetin
(EQST)
hemiterpene
compound
isolated
from
fungus
of
marine
sponge
origin,
which
has
antibacterial,
anti-inflammatory,
lipid-lowering,
weight
loss
effects.
Whether
EQST
anti-atherosclerotic
activity
not
been
reported.
In
this
study,
we
revealed
that
displayed
anti-
atherosclerosis
effects
through
inhibiting
macrophage
response,
uptake
foam
cell
formation
in
vitro,
finally
ameliorated
high-fat
diet
(HFD)-induced
AopE
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 6, 2024
Given
the
multifactorial
pathogenesis
of
atherosclerosis
(AS),
a
chronic
inflammatory
disease,
combination
therapy
arises
as
compelling
approach
to
effectively
address
complex
interplay
pathogenic
mechanisms
for
more
desired
treatment
outcome.
Here,
we
present
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(9), P. 9503 - 9522
Published: Aug. 29, 2024
Atherosclerosis
is
a
chronic
inflammatory
disease
that
causes
degenerative
and
productive
changes
in
the
arteries.
The
resulting
atherosclerotic
plaques
restrict
vessel
lumen,
causing
blood
flow
disturbances.
Plaques
are
formed
mainly
large-
medium-sized
arteries,
usually
at
bends
forks
where
there
turbulence
flow.
Depending
on
their
location,
they
can
lead
to
various
states
such
as
myocardial
infarction,
stroke,
renal
failure,
peripheral
vascular
diseases,
or
sudden
cardiac
death.
In
this
work,
we
reviewed
literature
early
detection
of
atherosclerosis
markers
application
photodynamic
therapy
atherosclerosis-related
diseases.
Herein,
described
roles
C-reactive
protein,
insulin,
osteopontin,
osteoprotegerin,
copeptin,
TGF-β
cytokine
family,
amino
acid
homocysteine.
Also,
discuss
role
microelements
iron,
copper,
zinc,
Vitamin
D
promoting
formation
plaque.
Dysregulation
administered
compounds
associated
with
an
increased
risk
atherosclerosis.
Additionally,
taking
into
account
pathophysiology
plaque
formation,
believe
maintaining
homeostasis
range
biomarkers
mentioned
article
crucial
for
slowing
down
process
development
stability
already
formed.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(43), P. 58072 - 58099
Published: Oct. 21, 2024
Atherosclerosis-induced
coronary
artery
disease
is
a
major
cause
of
cardiovascular
mortality.
Clinically,
conservative
treatment
strategies
for
atherosclerosis
still
focus
on
lifestyle
interventions
and
the
use
lipid-lowering
anticoagulant
medications.
Despite
achieving
some
therapeutic
effects,
these
approaches
are
limited
by
low
bioavailability,
long
intervention
periods,
significant
side
effects.
With
advancement
nanotechnology,
nanomaterials
have
demonstrated
extraordinary
potential
in
biomedical
field.
Their
excellent
biocompatibility,
surface
modifiability,
high
targeting
capability
not
only
enable
efficient
diagnosis
plaque
progression
but
also
allow
precise
drug
delivery
within
atherosclerotic
plaques,
significantly
enhancing
bioavailability
reducing
systemic
Here,
we
systematically
review
current
research
progress
field
to
summarize
types
their
applications
both
atherosclerosis.
Notably,
context
therapy,
provide
comprehensive
overview
nanomaterial
based
targeted
systems
different
cell
plaques.
Additionally,
address
persistent
challenge
clinical
translation
summarizing
issues
providing
directions
innovation
improvement
design.
Overall,
believe
that
this
summarizes
challenges
thereby
offering
insights
references
development
materials
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
Atherosclerosis
(AS)
stands
as
a
primary
cause
of
vascular
diseases
worldwide,
with
its
occurrence
and
progression
being
attributed
to
the
interplay
multiple
risk
factors.
Therefore,
it
is
imperative
develop
comprehensive
strategy
aimed
at
effectively
mitigating
reversing
AS.
Herein,
hydrogen
sulfide
(H
2
S)
donor
incorporated
into
thermal‐sensitive
polymer
possessing
an
upper
critical
solution
temperature
(UCST),
which
not
only
serves
novel
macromolecular
H
S
but
also
forms
targeted
nanocarrier
for
delivering
near
infrared
II
photothermal
agent,
achieving
gas‐photothermal
therapy
against
AS
notable
advantages.
For
one
aspect,
multifunctional
UCST
nanomedicine
could
target
atherosclerotic
plaque
perform
photoacoustic
imaging‐guided
S‐photothermal
reduce
ratio
en‐face
aortic
lesion
areas
from
17.2%
6.5%
alleviate
inflammatory
microenvironment.
another
inevitable
hepatic
accumulation
would
activate
5'‐adenosine
monophosphate
(AMP)‐activated
protein
kinase/mammalian
rapamycin
signaling
pathway,
thereby
enhancing
lipid
metabolism
reducing
plasma
triglyceride
levels.
This
transformation
waste
valuable
asset
further
aids
in
inhibiting
Consequently,
here
mediate
effective
attenuate
Biomolecules and Biomedicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
Atherosclerosis
is
a
chronic
inflammatory
disease
associated
with
lipid
deposition
in
the
vascular
intima.
Copper
vital
trace
element
implicated
onset
and
progression
of
atherosclerosis.
Excessive
intracellular
copper
accumulation
induces
unique
form
cell
death
termed
“cuproptosis.”
The
emergence
concept
cuproptosis
has
highlighted
potential
role
This
review
explores
regulatory
mechanisms
metabolism
cuproptosis,
summarizes
recent
findings
on
link
between
excess
atherosclerosis,
examines
how
may
influence
atherosclerosis
progression.
goal
to
propose
novel
diagnostic
therapeutic
strategies
for
through
lens
cuproptosis.